Four Markers Capture Triple-Negative Breast Cancer Cells in Blood Samples

Four Markers Capture Triple-Negative Breast Cancer Cells in Blood Samples

Researchers at Baylor College of Medicine have developed a new approach to isolating circulating tumor cells (CTCs) from liquid biopsies of patients with triple-negative breast cancer (TNBC). Through the identification of four new cell surface markers specific to TNBC cells, this work could address a major limitation that has historically prevented the use of CTCs in the diagnosis and monitoring of TNBC.  “The new markers detected cells that sta…

Finding new cell markers to track the most aggressive breast cancer in blood

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies. TNBC also is more likely to...